Literature DB >> 16052698

Alterations of serum cholinesterase in patients with gastric cancer.

Shan-Zhi Gu1, Xin-Han Zhao, Ping Quan, Sheng-Bin Li, Bo-Rong Pan.   

Abstract

AIM: To understand the correlation of serum cholinesterase (CHE) activity with gastric cancer and to assess their clinical significance.
METHODS: The velocity method was adopted to detect the activity of serum CHE in patients with gastric cancer and in patients with non-malignant tumor as controls.
RESULTS: The serum CHE activity in the treatment group was significantly lower than that in the control group with a very significant difference between the two groups (83.3:113.1,P = 0.0003). Age was significantly associated with the incidence of gastric cancer.
CONCLUSION: Serum CHE activity has a close relation with the incidence of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052698      PMCID: PMC4398718          DOI: 10.3748/wjg.v11.i29.4604

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  [Current therapies in dementia].

Authors:  Hiroyuki Arai
Journal:  Nihon Ronen Igakkai Zasshi       Date:  2004-05

2.  [Cholinesterase in the differential diagnosis of parenchymal and obstructive icterus and in the differentiation between malignant and benign obstruction].

Authors:  K Anic; A Ivandic; M Volaric; L Peric; L Getto; T Bacun
Journal:  Wien Med Wochenschr       Date:  1999

3.  Plasma cholinesterase activity in patients with uterine cervical cancer during radiotherapy.

Authors:  V Bradamante; E Smigovec; D Buković; J Geber; D Matanić
Journal:  Coll Antropol       Date:  2000-12

4.  Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease.

Authors:  Ching-ju Lu; Larry E Tune
Journal:  Am J Geriatr Psychiatry       Date:  2003 Jul-Aug       Impact factor: 4.105

5.  Understanding the latest advances in pharmacologic interventions for Alzheimer's disease.

Authors:  Christopher H van Dyck
Journal:  CNS Spectr       Date:  2004-07       Impact factor: 3.790

6.  Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States.

Authors:  Kristen Migliaccio-Walle; Denis Getsios; J Jaime Caro; Khajak J Ishak; Judith A O'Brien; George Papadopoulos
Journal:  Clin Ther       Date:  2003-06       Impact factor: 3.393

7.  Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure.

Authors:  A S Androne; K Hryniewicz; R Goldsmith; A Arwady; S D Katz
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

Review 8.  [Prevention of dementia: is it possible?].

Authors:  J L Pepin; S Myressiotis; S Ceulemans
Journal:  Rev Med Liege       Date:  2003-04

Review 9.  Recent developments in the synthesis of acetylcholinesterase inhibitors.

Authors:  José L Marco; M Carmo Carreiras
Journal:  Mini Rev Med Chem       Date:  2003-09       Impact factor: 3.862

10.  Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population.

Authors:  Brenda Eskenazi; Kim Harley; Asa Bradman; Erin Weltzien; Nicholas P Jewell; Dana B Barr; Clement E Furlong; Nina T Holland
Journal:  Environ Health Perspect       Date:  2004-07       Impact factor: 9.031

View more
  10 in total

1.  Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.

Authors:  Teppei Okamoto; Chikako Tsutaya; Shingo Hatakeyama; Sakae Konishi; Kazutaka Okita; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Tadashi Suzuki; Chikara Ohyama
Journal:  Int Urol Nephrol       Date:  2018-08-20       Impact factor: 2.370

2.  Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer.

Authors:  Antonio Rollan; Catterina Ferreccio; Alessandra Gederlini; Carolina Serrano; Javiera Torres; Paul Harris
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

3.  The impact of low serum cholinesterase levels on survival in patients with colorectal cancer.

Authors:  Yasuhiro Takano; Koichiro Haruki; Shu Tsukihara; Daisuke Ito; Hironori Kanno; Kyonsu Son; Nobuyoshi Hanyu; Ken Eto
Journal:  Int J Colorectal Dis       Date:  2022-03-15       Impact factor: 2.796

4.  Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Authors:  Teppei Okamoto; Shingo Hatakeyama; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Takuya Koie; Tadashi Suzuki; Chikara Ohyama
Journal:  Clin Exp Nephrol       Date:  2018-03-29       Impact factor: 2.801

5.  The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.

Authors:  Nina Poetsch; Alina Sturdza; Stefanie Aust; Stephan Polterauer; Christoph Grimm; Richard Schwameis; Richard Pötter; Heinz Koelbl; Alexander Reinthaller; Veronika Seebacher
Journal:  Strahlenther Onkol       Date:  2019-02-08       Impact factor: 3.621

6.  An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.

Authors:  Shan Lu; Ziqi Meng; Yingying Tan; Chao Wu; Zhihong Huang; Jiaqi Huang; Changgeng Fu; Antony Stalin; Siyu Guo; Xinkui Liu; Leiming You; Xiaojiaoyang Li; Jingyuan Zhang; Wei Zhou; Xiaomeng Zhang; Miaomiao Wang; Jiarui Wu
Journal:  BMC Complement Med Ther       Date:  2022-03-02

7.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

8.  Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.

Authors:  Takuya Koie; Chikara Ohyama; Jotaro Mikami; Hiromichi Iwamura; Naoki Fujita; Tendo Sato; Yuta Kojima; Ken Fukushi; Hayato Yamamoto; Atsushi Imai; Shingo Hatakeyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Masato Kitayama; Kazuyoshi Hirota
Journal:  ScientificWorldJournal       Date:  2014-03-04

9.  Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.

Authors:  Eva Valentina Klocker; Dominik Andreas Barth; Jakob Michael Riedl; Felix Prinz; Joanna Szkandera; Konstantin Schlick; Peter Kornprat; Karoline Lackner; Jörg Lindenmann; Herbert Stöger; Michael Stotz; Armin Gerger; Martin Pichler
Journal:  Cancers (Basel)       Date:  2020-05-04       Impact factor: 6.575

10.  Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer.

Authors:  Yanzhi Bi; Junling Zhang; Dongxiang Zeng; Lili Chen; Wei Ye; Quanliang Yang; Yang Ling
Journal:  Pathol Oncol Res       Date:  2021-03-25       Impact factor: 3.201

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.